Frantz EyeCare reports 98% of Light Adjustable Lens patients achieved refractive accuracy within ±0.50 D of target, exceeding published national cataract surgery benchmarks.
|Articles|February 1, 2003
New tools: Tactical portfolio helps ease retirement in today's market
It may not be any consolation to you, but many investors have become concerned about, or are now discouraged with, the performance of their investments. Standing by and watching years of savings and past gains slip away over a 2-year period has many people wondering what to do next. According to the September issue of the AARP Bulletin, more than $7 trillion has evaporated since this bear market started. Of this, about $700 billion disappeared in value within retirement savings. To give you another perspective, a dollar invested in the broad-based S&P 500 in March 2000 is now worth about 55 cents.
Advertisement
Advertisement
Related to this article
In this Q&A, Ping Moore, OD, covers emerging dry eye therapies, from selenium sulfide to next-gen cyclosporine, and how subtype-guided care shapes treatment choices.
Ophthalmology is projected to face one of the steepest physician shortages of any subspecialty by 2038.
Two investigational pipeline therapies take aim at the root causes of dry eye disease
Dry eye care pivots to root-cause diagnosis and personalized biologics/devices,
Cataract surgery becomes refractive: learn how IOL choices and preop counseling across distance, intermediate and near turn 20/20 into 20/happy.
Findings from the third annual State of Dry Eye survey link symptom management to quality of life gains, including lower anxiety and improved self-confidence.
June brings FDA clearance for Lumvoa, key retina and glaucoma trials, device deals, and hard truths on AI performance in eye care.
Advertisement
Advertisement